Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Pelzer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 15, 2007
Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated ratsPaula-Anahi Arias-Loza, Kai Hu, Charlotte Dienesch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Cardiovascular Research|June 14, 2005
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive ratsTheo Pelzer, Virginija Jazbutyte, Kai Hu, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.
Oncotarget|December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Hypertension (Dallas, Tex. : 1979)|August 16, 2012
The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heartPaula-Anahi Arias-Loza, Michael C Kreissl, Susanne Kneitz, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2006
Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated ratsPaula Anahi Arias-Loza, Kai Hu, Andreas Schäfer, et al.
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive ratsVirginija Jazbutyte, Kai Hu, Patricia Kruchten, et al.
Cardiovascular Research|December 7, 2007
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive ratsVirginija Jazbutyte, Paula Anahi Arias-Loza, Kai Hu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|June 15, 2007
Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated ratsPaula-Anahi Arias-Loza, Kai Hu, Charlotte Dienesch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Cardiovascular Research|June 14, 2005
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive ratsTheo Pelzer, Virginija Jazbutyte, Kai Hu, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.
Oncotarget|December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Hypertension (Dallas, Tex. : 1979)|August 16, 2012
The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heartPaula-Anahi Arias-Loza, Michael C Kreissl, Susanne Kneitz, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2006
Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated ratsPaula Anahi Arias-Loza, Kai Hu, Andreas Schäfer, et al.
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive ratsVirginija Jazbutyte, Kai Hu, Patricia Kruchten, et al.
Cardiovascular Research|December 7, 2007
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive ratsVirginija Jazbutyte, Paula Anahi Arias-Loza, Kai Hu, et al.
Pageof 4